Metrics to compare | BSFAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBSFABPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −3.3x | −0.2x | |
PEG Ratio | −0.04 | −0.03 | 0.00 | |
Price/Book | 1.0x | 1.2x | 2.6x | |
Price / LTM Sales | 33.8x | 3.6x | 2.7x | |
Upside (Analyst Target) | - | 272.9% | 66.0% | |
Fair Value Upside | Unlock | 7.6% | 10.8% | Unlock |
BSF Enterprise Plc, together with its subsidiaries, develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong. The company acquires businesses in the biotechnology, marketing, and e-commerce sectors. It also engages in biotechnology start-up; lab-grown cornea and meat research; and development of skin technology. In addition, the company engages in the humanoid robotics and physical AI platform designed to address the outer-covering and tactile sensor integration facing volume robotics manufacturing. The company was incorporated in 2018 and is based in London, the United Kingdom.